Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
End Stage Renal Disease on Dialysis: later-stage trial registry
3 of 10 indexed End Stage Renal Disease on Dialysis trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #1,724 of 28,707 conditions by registered trial count.
10 US clinical trials · 3 currently recruiting · #1,724 of 28,707 conditions by registered trial count
End Stage Renal Disease on Dialysis: 10 US clinical trials tracked, 3 recruiting.
End Stage Renal Disease on Dialysis is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Vanderbilt University Medical Center, running 2 of these trials.
Enrollment posture brief
Registry condition end-stage-renal-disease-on-dialysis
OPEN 3 | RECR 30% | LATE 2 | EARLY 0 | RANK #1724 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adrenocortical Carcinoma (30% recruiting · 10 trials)
End Stage Renal Disease on Dialysis lists 3 open slots (30% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for End Stage Renal Disease on Dialysis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
End Stage Renal Disease on Dialysis is recruiting below its size-band peers.
3 of 10 indexed trials (30%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates End Stage Renal Disease on Dialysis research.
Vanderbilt University Medical Center accounts for 2 of 10 trials (20%). 9 distinct sponsors appear on at least one study for this condition label.
-
Most End Stage Renal Disease on Dialysis trials plan to enrol fewer than 100 people.
Median target enrolment is 41 among the 10 trials that report a genuine target (sentinel values excluded). 8 of those (80%) plan for fewer than 100 participants.
-
End Stage Renal Disease on Dialysis research is mostly interventional.
9 interventional and 1 observational studies make up this index (90% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
10 total, page 1 of 1
Comparing Surgical and Endovascular Arteriovenous Fistula Creation
University of California, Los Angeles
NCT05654103
Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD
University of Illinois at Chicago
NCT07014111
Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease
Yale University
NCT05671991
The Home Blood Pressure (BP) Trial
University of Washington
NCT05159999
MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence
Vanderbilt University Medical Center
NCT05735743
DIALYSIS-TIR Study
University of Texas Southwestern Medical Center
NCT06042153
The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300
Outset Medical
NCT05947708
A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease
Sanifit Therapeutics S. A.
NCT04487301
Motivational Strategies To Empower African Americans To Improve Dialysis Adherence
Vanderbilt University Medical Center
NCT05003115
First Evaluation of the Moda-Flx Hemodialysis System™ in Real World Clinical Settings
Diality
NCT06581393
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on End Stage Renal Disease on Dialysis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on End Stage Renal Disease on Dialysis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this End Stage Renal Disease on Dialysis page
10 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 End Stage Renal Disease on Dialysis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Vanderbilt University Medical Center sponsors the most End Stage Renal Disease on Dialysis trials on record, review their full trial history before evaluating a specific study. See Vanderbilt University Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This End Stage Renal Disease on Dialysis condition card totals 10 registered trials; most-linked intervention Motivational interviewing; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.